MD PhD Strategies
Long only, special situations

GI Dynamics: A Speculative Play On Obesity And Weight Loss?

GI Dynamics is a little-known Massachusetts company with a novel non-surgical endoscopic therapy that causes weight loss. I discovered GI Dynamics (OTC:GIDYL) while traveling in Australia in 2011. It's a company new to Seeking Alpha readers and to most investors, and may hold promise for considerable share price appreciation for its "diabesity" treatment called EndoBarrier.

GI Dynamics was founded in 2003 and, for somewhat arcane reasons, originally sought capital via a 2011 IPO in Australia, seemingly on the basis that EndoBarrier would be approved sooner there than in the US, where it is still investigational. EndoBarrier is now approved and in use in Australia, Austria, Chile, Germany, Israel, Italy, Netherlands, and the United Kingdom. GIDYL began trading on...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details